Stocks to Buy, Sell or Hold – What brokerages say?
– Credit Suisse on Ultratech Cement (CMP: 6843)
Maintain Outperform, Target 7700
– Morgan Stanley on Nykaa (CMP: 175)
Maintain Overweight, Target 314
– Citi on Lupin (CMP: 720)
Maintain Buy, Target raised to 840 from 820
If gpiriva is approved, co is expected to enjoy sole exclusivity in a
$500-700m market for next couple of yrs
Product has potential to repair margins from sub 10% to c17-18% levels
On other hand, if approval is delayed following additional queries from USFDA,
believe downside is ltd as strong flu season in US
& impact of Suprep can help margins in 3QFY23, limiting downside
– Credit Suisse on Shree Cement (CMP: 23265)
Maintain Neutral, Target 21000
(Disclaimer: The views/suggestions/advises expressed here in this article is solely by investment experts. Zee Business suggests its readers to consult with their investment advisers before making any financial decision.)
